Inovio Investors Get Derivative Deal OK'd Over Vaccine Claims
Investors in biotechnology firm Inovio Pharmaceuticals Inc. have received an initial green light from a Philadelphia federal judge for their agreement to settle their derivative action against the company's brass over...To view the full article, register now.
Already a subscriber? Click here to view full article